“acorda-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Sunovion’s FDA Rejection Gives Acorda Parkinson’s Drug Breathing Room 01/31/19 Boston
Acorda Gets FDA Nod for New Parkinson’s Drug, But Rival Looms 12/24/18 New York
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Acorda’s Tough Week Continues as FDA Delays Parkinson’s Drug Review 09/13/18 New York
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
With Acorda Data, Experts Weigh the Benefits of New Parkinson’s Drugs 04/25/18 New York
Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More 03/02/18 National
Activist Investor Scopia Gets Two Board Seats in Deal with Acorda 02/28/18 New York
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Sunovion Parkinson’s Drug Heads to FDA, Setting Up Battle With Acorda 01/30/18 Boston
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another 11/20/17 New York
Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study 11/15/17 New York
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble 08/29/17 New York
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
MS Drug Patent Rulings Give Biogen Win, Acorda Loss in Separate Suits 03/31/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails 11/21/16 New York
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug 05/20/16 New York
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push 04/13/16 Boston
Page 1 of 3 next page »